BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Given Average Recommendation of “Moderate Buy” by Brokerages
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Get Free Report) has earned a consensus recommendation of “Moderate Buy” from the twenty-four analysts that are currently covering the stock, Marketbeat.com reports. Nine analysts have rated the stock with a hold recommendation and fifteen have given a buy recommendation to the company. The average 1-year target price among analysts […]
More Stories
Merck & Co., Inc. (NYSE:MRK) Holdings Raised by Capital International Inc. CA
Capital International Inc. CA increased its stake in Merck & Co., Inc. (NYSE:MRK – Free Report) by 164.7% during the...
Capital International Inc. CA Cuts Stake in Mondelez International, Inc. (NASDAQ:MDLZ)
Capital International Inc. CA lowered its stake in Mondelez International, Inc. (NASDAQ:MDLZ – Free Report) by 23.0% in the first...
CSX Co. (NASDAQ:CSX) Shares Acquired by Capital International Inc. CA
Capital International Inc. CA boosted its holdings in CSX Co. (NASDAQ:CSX – Free Report) by 15.3% during the first quarter,...
Capital Group Private Client Services Inc. Buys 3,047 Shares of Union Pacific Co. (NYSE:UNP)
Capital Group Private Client Services Inc. increased its holdings in Union Pacific Co. (NYSE:UNP – Free Report) by 7.2% during...
Kemira Oyj (OTCMKTS:KOYJF) Short Interest Update
Kemira Oyj (OTCMKTS:KOYJF – Get Free Report) saw a large growth in short interest during the month of July. As...
Short Interest in General Enterprise Ventures, Inc. (OTCMKTS:GEVI) Increases By 197.8%
General Enterprise Ventures, Inc. (OTCMKTS:GEVI – Get Free Report) saw a significant increase in short interest in the month of...